Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04476758 · ClinicalTrials.gov registry record
Immune Profiles in CF Fungal Infection
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 24
- Enrollment target
NCT04476758 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 24 participants.
The verdict
NCT04476758 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This study is investigating the role of allergic (Th2) inflammation in patients with Cystic Fibrosis (CF) and history of fungal infection and/or Allergic Bronchopulmonary Aspergillosis. Little is known about fungal infection in CF and conflicting results exist on whether this results in worse lung function over time. There is concern that persistent fungal infection can result in worse clinical outcome measures in patients with CF. Also, it is unclear how ABPA develops, but may be related to the amount of fungus a patient with CF is infected with. This study looks at inflammatory patterns and allergic responses to fungal elements to help identify biomarkers and signs of allergic disease in fungally infected patients with CF.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2023-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04476758
The ClinicalTrials.gov registry entry for NCT04476758 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04476758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04476758 about?
NCT04476758 is a clinical study titled "Immune Profiles in CF Fungal Infection". This study is investigating the role of allergic (Th2) inflammation in patients with Cystic Fibrosis (CF) and history of fungal infection and/or Allergic Bronchopulmonary Aspergillosis. Little is known about fungal infection in CF and conflicting results exist on whether this results in worse lung f...
What is the current status of trial NCT04476758?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2021-02-10. Estimated completion is 2023-10-30.
Who is sponsoring clinical trial NCT04476758?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.